Blog Archives

We are happy to celebrate that our products appear now in more than 100 peer reviewed publications!!!

Thanks to all speakers and participants for this great first edition of the Cellular Allergy Innovation Forum at Basel Life 2019.

At this year`s 14th Dresden Symposium on Autoantibodies the diagnostic relevance of anti-HNK-1 antibodies has been presented for the first time.

We are very pleased to announce the United States Food and Drug Administration (FDA) 510(k) clearance for the BÜHLMANN CALEX® Cap.